Co-Diagnostics (HAM:C970) Shares Buyback Ratio %: -304.56 (As of Sep. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:C970 Co-Diagnostics Inc HAM:C970
61 GF Score
Price €5.55
GF Value €8.63
! 5 Warning Signs
View Full Analysis

What is Co-Diagnostics Shares Buyback Ratio %?

Co-Diagnostics HAM:C970 61 Shares Buyback Ratio % is -304.56 as of Sep. 11, 2026. GuruFocus rates HAM:C970 with a GF Score™ of 61/100 and a GF Value™ of €8.63. The stock has 5 warning signs investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Co-Diagnostics's current shares buyback ratio was -304.56%.

Co-Diagnostics Shares Buyback Ratio % Related Terms

Co-Diagnostics Shares Buyback Ratio % Historical Data

* Premium members only.

The historical data trend for Co-Diagnostics's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Co-Diagnostics Shares Buyback Ratio % Chart

Co-Diagnostics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.38 8.70 -1.26 -5.76 -90.11

Co-Diagnostics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.77 -33.08 -30.53 -71.93 -35.45
HAM:C970
61GF Score
Co-Diagnostics Inc HAM:C970
Shares Buyback Ratio % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Co-Diagnostics Shares Buyback Ratio % Calculation

Co-Diagnostics's Shares Buyback Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2024 ) - Shares Outstanding (EOP) (A: Dec. 2025 )) / Shares Outstanding (EOP) (A: Dec. 2024 )
=(1.102 - 2.095) / 1.102
=-90.11%

Co-Diagnostics's Shares Buyback Ratio for the quarter that ended in Jun. 2026 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Mar. 2026 ) - Shares Outstanding (EOP) (A: Jun. 2026 )) / Shares Outstanding (EOP) (A: Mar. 2026 )
=(3.602 - 4.879) / 3.602
=-35.45%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Shares Buyback Ratio % →
What does a Shares Buyback Ratio % of -304.56 mean?
Co-Diagnostics (HAM:C970) has a Shares Buyback Ratio % of -304.56 as of Sep. 11, 2026. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Co-Diagnostics and its competitors.
Is Co-Diagnostics' Shares Buyback Ratio % too high?
Co-Diagnostics' current Shares Buyback Ratio % is -304.56. Overall, Co-Diagnostics has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Co-Diagnostics' Shares Buyback Ratio % compare to AIDX and TRIB?
Co-Diagnostics' Shares Buyback Ratio % of -304.56 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Buyback Ratio % for a Medical Devices & Instruments company?
A good Shares Buyback Ratio % depends on the Medical Devices & Instruments industry context. However, Shares Buyback Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Buyback Ratio % mean?
A high Shares Buyback Ratio % can signal that a stock is expensive relative to its fundamentals. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Co-Diagnostics and its competitors. Co-Diagnostics's current Shares Buyback Ratio % is -304.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Co-Diagnostics stock overvalued right now?
Co-Diagnostics (HAM:C970) has a current Shares Buyback Ratio % of -304.56. The stock's GF Value™ is €8.63, compared to a current price of €5.55 — trading 35.7% below its estimated fair value. The current Shares Buyback Ratio % is -304.56. Co-Diagnostics' overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Buyback Ratio % calculated?
Shares Buyback Ratio % is calculated from a company's financial statements. For Co-Diagnostics (HAM:C970), the current Shares Buyback Ratio % is -304.56 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Co-Diagnostics (HAM:C970) Overvalued in 2026?

Based on GuruFocus' analysis, Co-Diagnostics stock appears to be undervalued. The current stock price of €5.55 is trading 35.7% below its estimated GF Value™ of €8.63.

Key valuation signals for HAM:C970:

  • Shares Buyback Ratio %: -304.56
  • GF Value™: €8.63 vs. price of €5.55 (35.7% below fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the HAM:C970 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Co-Diagnostics Business Description

Other Exchanges CODX:USA0A50:UK
Address 2401 S. Foothill Drive, Suite D, Salt Lake City, UT, USA, 84109
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
61GF Score

Get the complete analysis for HAM:C970

Shares Buyback Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.55
Price
€8.63
GF Value